Palliative care initiated in the emergency department: A cluster randomized clinical trial Journal Article


Authors: Grudzen, C. R.; Siman, N.; Cuthel, A. M.; Adeyemi, O.; Yamarik, R. L.; Goldfeld, K. S.; Zimny, E.; and the PRIM-ER Investigators
Article Title: Palliative care initiated in the emergency department: A cluster randomized clinical trial
Abstract: Importance: The emergency department (ED) offers an opportunity to initiate palliative care for older adults with serious, life-limiting illness. Objective: To assess the effect of a multicomponent intervention to initiate palliative care in the ED on hospital admission, subsequent health care use, and survival in older adults with serious, life-limiting illness. Design, Setting, and Participants: Cluster randomized, stepped-wedge, clinical trial including patients aged 66 years or older who visited 1 of 29 EDs across the US between May 1, 2018, and December 31, 2022, had 12 months of prior Medicare enrollment, and a Gagne comorbidity score greater than 6, representing a risk of short-term mortality greater than 30%. Nursing home patients were excluded. Intervention: A multicomponent intervention (the Primary Palliative Care for Emergency Medicine intervention) included (1) evidence-based multidisciplinary education; (2) simulation-based workshops on serious illness communication; (3) clinical decision support; and (4) audit and feedback for ED clinical staff. Main Outcome and Measures: The primary outcome was hospital admission. The secondary outcomes included subsequent health care use and survival at 6 months. Results: There were 98922 initial ED visits during the study period (median age, 77 years [IQR, 71-84 years]; 50% were female; 13% were Black and 78% were White; and the median Gagne comorbidity score was 8 [IQR, 7-10]). The rate of hospital admission was 64.4% during the preintervention period vs 61.3% during the postintervention period (absolute difference, -3.1% [95% CI, -3.7% to -2.5%]; adjusted odds ratio [OR], 1.03 [95% CI, 0.93 to 1.14]). There was no difference in the secondary outcomes before vs after the intervention. The rate of admission to an intensive care unit was 7.8% during the preintervention period vs 6.7% during the postintervention period (adjusted OR, 0.98 [95% CI, 0.83 to 1.15]). The rate of at least 1 revisit to the ED was 34.2% during the preintervention period vs 32.2% during the postintervention period (adjusted OR, 1.00 [95% CI, 0.91 to 1.09]). The rate of hospice use was 17.7% during the preintervention period vs 17.2% during the postintervention period (adjusted OR, 1.04 [95% CI, 0.93 to 1.16]). The rate of home health use was 42.0% during the preintervention period vs 38.1% during the postintervention period (adjusted OR, 1.01 [95% CI, 0.92 to 1.10]). The rate of at least 1 hospital readmission was 41.0% during the preintervention period vs 36.6% during the postintervention period (adjusted OR, 1.01 [95% CI, 0.92 to 1.10]). The rate of death was 28.1% during the preintervention period vs 28.7% during the postintervention period (adjusted OR, 1.07 [95% CI, 0.98 to 1.18]). Conclusions and Relevance: This multicomponent intervention to initiate palliative care in the ED did not have an effect on hospital admission, subsequent health care use, or short-term mortality in older adults with serious, life-limiting illness. © 2025 American Medical Association. All rights reserved, including those for text and data mining, AI training, and similar technologies.
Keywords: controlled study; aged; aged, 80 and over; clinical trial; palliative care; randomized controlled trial; palliative therapy; emergency service, hospital; hospitalization; multicenter study; decision support systems, clinical; very elderly; humans; human; male; female; clinical decision support system; hospital emergency service
Journal Title: JAMA - Journal of the American Medical Association
Volume: 333
Issue: 7
ISSN: 0098-7484
Publisher: American Medical Association  
Date Published: 2025-02-18
Start Page: 599
End Page: 608
Language: English
DOI: 10.1001/jama.2024.23696
PUBMED: 39813042
PROVIDER: scopus
PMCID: PMC11836764
DOI/URL:
Notes: The MSK Cancer Center Support Grant (P30 CA008748) is acknowledged in the PubMed record and PDF. Corresponding MSK author is Corita R. Grudzen -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Corita Reilley Grudzen
    31 Grudzen